Asia Pacific Continuous Glucose Monitoring Systems (CGMS) Market (2016-2022)
The Asia Pacific Continuous Glucose Monitoring Systems (CGMS) Market is expected to grow at a CAGR of 32% during 2016 -2022.
The inherent benefits of CGMS are far superior than self-monitoring blood glucose (SMBG) devices i.e., POC glucometers. Also, the data obtained by CGMS and trend analysis is highly accurate and reliable as compared to other SMBG devices/POC glucometers. Such unparalleled superiority would drive the market adoption much higher among the end-users.
Increased and ongoing efforts of ‘patient-education’ and ‘screening for diabetes’ programs would increase the awareness levels and eventually would drive the overall diabetes treatment and management market growth. Significantly growing purchasing power among the end-user/patient base in the developing and underdeveloped regions would act as a major factor driving the market during the forecast period.
The report highlights the adoption of Continuous Glucose Monitoring Systems in Asia Pacific. Based on the Component, the Asia Pacific Continuous Glucose Monitoring Systems Market is segmented into Sensors, Transmitters & Receivers and Integrated Insulin pumps segment. Based on the End user, the market is bifurcated into Diagnostic centers/clinics, ICUs and Home Healthcare segments. The countries included in the report are China, Japan, India, South Korea, Singapore, Malaysia and Rest of Asia Pacific.
Key Players profiled in the report includes Roche Diagnostics, Abbott Laboratories, Dexcom Inc., Novo Nordisk, Ypsomed AG, GlySens Incorporated, Medtronic Plc and Johnson & Johnson.
The inherent benefits of CGMS are far superior than self-monitoring blood glucose (SMBG) devices i.e., POC glucometers. Also, the data obtained by CGMS and trend analysis is highly accurate and reliable as compared to other SMBG devices/POC glucometers. Such unparalleled superiority would drive the market adoption much higher among the end-users.
Increased and ongoing efforts of ‘patient-education’ and ‘screening for diabetes’ programs would increase the awareness levels and eventually would drive the overall diabetes treatment and management market growth. Significantly growing purchasing power among the end-user/patient base in the developing and underdeveloped regions would act as a major factor driving the market during the forecast period.
The report highlights the adoption of Continuous Glucose Monitoring Systems in Asia Pacific. Based on the Component, the Asia Pacific Continuous Glucose Monitoring Systems Market is segmented into Sensors, Transmitters & Receivers and Integrated Insulin pumps segment. Based on the End user, the market is bifurcated into Diagnostic centers/clinics, ICUs and Home Healthcare segments. The countries included in the report are China, Japan, India, South Korea, Singapore, Malaysia and Rest of Asia Pacific.
Key Players profiled in the report includes Roche Diagnostics, Abbott Laboratories, Dexcom Inc., Novo Nordisk, Ypsomed AG, GlySens Incorporated, Medtronic Plc and Johnson & Johnson.
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Continuous Glucose Monitoring Systems Market, by Component
1.4.2 Asia Pacific Continuous Glucose Monitoring Systems Market, by End User
1.4.3 Asia Pacific Continuous Glucose Monitoring Systems Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.2 Key Influencing Factors
2.2.1 Drivers
2.2.2 Restraints
2.2.3 Opportunities
2.3 Asia Pacific Continuous Glucose Monitoring Systems Market
2.3.1 Asia Pacific Continuous Glucose Monitoring Systems Market - By Component
2.3.2 Asia Pacific Continuous Glucose Monitoring Systems Market - By End User
CHAPTER 3. ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT
3.1 Asia Pacific Continuous Glucose Monitoring Systems Sensors Market - By Country
3.2 Asia Pacific Continuous Glucose Monitoring Transmitters & Receivers Market - By Country
3.2.1 Asia Pacific Continuous Glucose Monitoring Systems Integrated Insulin pumps Market - By Country
CHAPTER 4. ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER
4.1.1 Asia Pacific Diagnostic centers/clinics Continuous Glucose Monitoring Systems Market - By Country
4.1.2 Asia Pacific ICUs Continuous Glucose Monitoring Systems Market - By Country
4.1.3 Asia Pacific Home Healthcare Continuous Glucose Monitoring Systems Market - By Country
CHAPTER 5. ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY
5.1 China Continuous Glucose Monitoring Systems Market
5.1.1 China Continuous Glucose Monitoring Systems Market - By Component
5.1.2 China Continuous Glucose Monitoring Systems Market - By End User
5.2 Japan Continuous Glucose Monitoring Systems Market
5.2.1 Japan Continuous Glucose Monitoring Systems Market - By Component
5.2.2 Japan Continuous Glucose Monitoring Systems Market - By End User
5.3 India Continuous Glucose Monitoring Systems Market
5.3.1 India Continuous Glucose Monitoring Systems Market - By Component
5.3.2 India Continuous Glucose Monitoring Systems Market - By End User
5.4 South Korea Continuous Glucose Monitoring Systems Market
5.4.1 South Korea Continuous Glucose Monitoring Systems Market - By Component
5.4.2 South Korea Continuous Glucose Monitoring Systems Market - By End User
5.5 Singapore Continuous Glucose Monitoring Systems Market
5.5.1 Singapore Continuous Glucose Monitoring Systems Market - By Component
5.5.2 Singapore Continuous Glucose Monitoring Systems Market - By End User
5.6 Malaysia Continuous Glucose Monitoring Systems Market
5.6.1 Malaysia Continuous Glucose Monitoring Systems Market - By Component
5.6.2 Malaysia Continuous Glucose Monitoring Systems Market - By End User
5.7 Rest of Asia Pacific Continuous Glucose Monitoring Systems Market
5.7.1 Rest of Asia Pacific Continuous Glucose Monitoring Systems Market - By Component
5.7.2 Rest of Asia Pacific Continuous Glucose Monitoring Systems Market - By End User
CHAPTER 6. COMPANY PROFILE
6.1 Roche Diagnostics.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental Analysis
6.1.4 Research & Development Analysis
6.2 Abbott Laboratories
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental Analysis
6.2.4 Research & Development Analysis
6.3 Dexcom, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Research & Development Analysis
6.4 Novo Nordisk.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.4.4 Research & Development Analysis
6.5 Ypsomed AG
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental Analysis
6.6 GlySens Incorporated.
6.6.1 Company Overview
6.7 Medtronic Plc
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental Analysis
6.7.4 Research & Development Analysis
6.8 Johnson & Johnson.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Research & Development Analysis
6.8.4 Segmental Analysis
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Continuous Glucose Monitoring Systems Market, by Component
1.4.2 Asia Pacific Continuous Glucose Monitoring Systems Market, by End User
1.4.3 Asia Pacific Continuous Glucose Monitoring Systems Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.2 Key Influencing Factors
2.2.1 Drivers
2.2.2 Restraints
2.2.3 Opportunities
2.3 Asia Pacific Continuous Glucose Monitoring Systems Market
2.3.1 Asia Pacific Continuous Glucose Monitoring Systems Market - By Component
2.3.2 Asia Pacific Continuous Glucose Monitoring Systems Market - By End User
CHAPTER 3. ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT
3.1 Asia Pacific Continuous Glucose Monitoring Systems Sensors Market - By Country
3.2 Asia Pacific Continuous Glucose Monitoring Transmitters & Receivers Market - By Country
3.2.1 Asia Pacific Continuous Glucose Monitoring Systems Integrated Insulin pumps Market - By Country
CHAPTER 4. ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER
4.1.1 Asia Pacific Diagnostic centers/clinics Continuous Glucose Monitoring Systems Market - By Country
4.1.2 Asia Pacific ICUs Continuous Glucose Monitoring Systems Market - By Country
4.1.3 Asia Pacific Home Healthcare Continuous Glucose Monitoring Systems Market - By Country
CHAPTER 5. ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY
5.1 China Continuous Glucose Monitoring Systems Market
5.1.1 China Continuous Glucose Monitoring Systems Market - By Component
5.1.2 China Continuous Glucose Monitoring Systems Market - By End User
5.2 Japan Continuous Glucose Monitoring Systems Market
5.2.1 Japan Continuous Glucose Monitoring Systems Market - By Component
5.2.2 Japan Continuous Glucose Monitoring Systems Market - By End User
5.3 India Continuous Glucose Monitoring Systems Market
5.3.1 India Continuous Glucose Monitoring Systems Market - By Component
5.3.2 India Continuous Glucose Monitoring Systems Market - By End User
5.4 South Korea Continuous Glucose Monitoring Systems Market
5.4.1 South Korea Continuous Glucose Monitoring Systems Market - By Component
5.4.2 South Korea Continuous Glucose Monitoring Systems Market - By End User
5.5 Singapore Continuous Glucose Monitoring Systems Market
5.5.1 Singapore Continuous Glucose Monitoring Systems Market - By Component
5.5.2 Singapore Continuous Glucose Monitoring Systems Market - By End User
5.6 Malaysia Continuous Glucose Monitoring Systems Market
5.6.1 Malaysia Continuous Glucose Monitoring Systems Market - By Component
5.6.2 Malaysia Continuous Glucose Monitoring Systems Market - By End User
5.7 Rest of Asia Pacific Continuous Glucose Monitoring Systems Market
5.7.1 Rest of Asia Pacific Continuous Glucose Monitoring Systems Market - By Component
5.7.2 Rest of Asia Pacific Continuous Glucose Monitoring Systems Market - By End User
CHAPTER 6. COMPANY PROFILE
6.1 Roche Diagnostics.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental Analysis
6.1.4 Research & Development Analysis
6.2 Abbott Laboratories
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental Analysis
6.2.4 Research & Development Analysis
6.3 Dexcom, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Research & Development Analysis
6.4 Novo Nordisk.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.4.4 Research & Development Analysis
6.5 Ypsomed AG
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental Analysis
6.6 GlySens Incorporated.
6.6.1 Company Overview
6.7 Medtronic Plc
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental Analysis
6.7.4 Research & Development Analysis
6.8 Johnson & Johnson.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Research & Development Analysis
6.8.4 Segmental Analysis
LIST OF TABLES
TABLE 1 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 2 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 3 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 4 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 5 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 6 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 7 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 8 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 9 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS SENSORS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 10 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS SENSORS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 11 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING TRANSMITTERS & RECEIVERS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 12 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING TRANSMITTERS & RECEIVERS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 13 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS INTEGRATED INSULIN PUMPS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 14 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS INTEGRATED INSULIN PUMPS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 15 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 16 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 17 ASIA PACIFIC DIAGNOSTIC CENTERS/CLINICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 18 ASIA PACIFIC DIAGNOSTIC CENTERS/CLINICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 19 ASIA PACIFIC ICUS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 20 ASIA PACIFIC ICUS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 21 ASIA PACIFIC HOME HEALTHCARE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 22 ASIA PACIFIC HOME HEALTHCARE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 23 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 24 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 25 CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 26 CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 27 CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 28 CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 29 CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 30 CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 31 JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 32 JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 33 JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 34 JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 35 JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 36 JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 37 INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 38 INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 39 INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 40 INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 41 INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 42 INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 43 SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 44 SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 45 SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 46 SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 47 SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 48 SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 49 SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 50 SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 51 SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 52 SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 53 SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 54 SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 55 MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 56 MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 57 MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 58 MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 59 MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 60 MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 61 REST OF ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 62 REST OF ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 63 REST OF ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 64 REST OF ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 65 REST OF ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 66 REST OF ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 67 KEY INFORMATION - ROCHE DIAGNOSTICS.
TABLE 68 KEY INFORMATION - ABBOTT LABORATORIES.
TABLE 69 KEY INFORMATION - DEXCOM, INC.
TABLE 70 KEY INFORMATION - NOVO NORDISK.
TABLE 71 KEY INFORMATION - YPSOMED AG.
TABLE 72 KEY INFORMATION - GLYSENS INCORPORATED.
TABLE 73 KEY INFORMATION - MEDTRONIC PLC
TABLE 74 KEY INFORMATION - JOHNSON & JOHNSON.
TABLE 1 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 2 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 3 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 4 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 5 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 6 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 7 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 8 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 9 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS SENSORS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 10 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS SENSORS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 11 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING TRANSMITTERS & RECEIVERS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 12 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING TRANSMITTERS & RECEIVERS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 13 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS INTEGRATED INSULIN PUMPS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 14 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS INTEGRATED INSULIN PUMPS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 15 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 16 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 17 ASIA PACIFIC DIAGNOSTIC CENTERS/CLINICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 18 ASIA PACIFIC DIAGNOSTIC CENTERS/CLINICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 19 ASIA PACIFIC ICUS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 20 ASIA PACIFIC ICUS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 21 ASIA PACIFIC HOME HEALTHCARE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 22 ASIA PACIFIC HOME HEALTHCARE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 23 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 24 ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 25 CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 26 CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 27 CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 28 CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 29 CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 30 CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 31 JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 32 JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 33 JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 34 JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 35 JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 36 JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 37 INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 38 INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 39 INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 40 INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 41 INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 42 INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 43 SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 44 SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 45 SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 46 SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 47 SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 48 SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 49 SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 50 SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 51 SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 52 SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 53 SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 54 SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 55 MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 56 MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 57 MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 58 MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 59 MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 60 MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 61 REST OF ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 62 REST OF ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 63 REST OF ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 64 REST OF ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 65 REST OF ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 66 REST OF ASIA PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 67 KEY INFORMATION - ROCHE DIAGNOSTICS.
TABLE 68 KEY INFORMATION - ABBOTT LABORATORIES.
TABLE 69 KEY INFORMATION - DEXCOM, INC.
TABLE 70 KEY INFORMATION - NOVO NORDISK.
TABLE 71 KEY INFORMATION - YPSOMED AG.
TABLE 72 KEY INFORMATION - GLYSENS INCORPORATED.
TABLE 73 KEY INFORMATION - MEDTRONIC PLC
TABLE 74 KEY INFORMATION - JOHNSON & JOHNSON.
